SEC Filings
Baxter Targets Net Zero By 2050, With Renewable Electricity Goal Due In 2040
The healthcare-products company also set supplier climate goals and a $275 million target for investment in underserved communities.
Baxter International (BAX) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
SEC Filings
The healthcare-products company also set supplier climate goals and a $275 million target for investment in underserved communities.
SEC Filings
Baxter retired $864 million of bonds for $600 million, while the FDA sent a Warning Letter over its Round Lake injectables plant.
Markets
Adjusted profit per share fell on a higher tax rate, and Baxter said it will stop making cephalosporin drugs at its Round Lake plant.
Earnings
Andrew Hider also warned that comparisons will toughen for the $342 million unit, and for drug compounding, which grew 9%.
Earnings
The CFO says the 2027 hit won't simply mirror the lost profit, and the exit also eases issues in a recent FDA warning letter.
Earnings
Third-quarter sales rose 5% to $2.98 billion, but a higher tax rate cut adjusted earnings per share from $0.69 a year earlier.
Markets
A warning letter lists four sets of manufacturing violations at the Illinois injectables plant and asks for independent assessments.